Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Menlo Park, USA
1490 O’Brien Drive
Suite A
Menlo Park, CA, 94025
USA

People

President, CEO and Co-Founder
Board of Directors
Boards of directors

Funding

Tags

Auxogyn

Auxogyn is revolutionizing the field of reproductive medicine by translating scientific discoveries in early embryo development into valuable clinical tools. The Company’s flagship product, the Eeva™ Test, is designed to deliver consistent, objective and quantitative information regarding embryo viability that reproductive endocrinologists and infertility patients can use to make important treatment decisions.

Recent Milestones

  • Dollar
    Auxogyn received $5.53M in Series B funding. (9/16/13)
    Posted 9/17/13 at 7:04pm via sec.gov
  • Dollar
    Auxogyn received $500k in Series B funding. (7/30/13)
    Posted 8/1/13 at 1:49am via sec.gov
  • Dollar
    Auxogyn received $18M in Series B funding. (6/5/12)
    Posted 6/5/12 at 6:08pm via finsmes.com
  • Dollar
    Auxogyn received $20M in Series A funding. (2/2/12)
    Posted 2/2/12 at 7:11pm via bizjournals.com
  • Check
    Auxogyn added Lissa Goldenstein as President, CEO and Co-Founder.
    Posted 2/2/12 at 7:11pm

Videos

Screenshots

Sources

  1. Auxogyn raises $20M in Series A funds (bizjournals.com) [edit]
  2. Auxogyn Raises $18M in Series B Financing (finsmes.com) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
Edit This Page
Last Edited 1/1/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy